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Summary 
 
Pharmaceuticals are highly diverse group of compounds used for treating and preventing diseases in 
humans and animals. They are designed to be biologically active and therefore they might 
negatively affect non-target living organisms. Owing to the advances of different analytical 
methodologies during the last decade, the widespread occurrence of these compounds in the 
environment was demonstrated. Although they are present in the environment in ng/L 
concentrations the proof of their existence in the environment lead to an arising social and scientific 
awareness. Many studies showed that the main point of collection and subsequent release of 
pharmaceuticals into the environment are wastewater treatment plants, suggesting that their upgrade 
and implementation of advanced treatment technologies are required. 
This work presents the results of use of some AOPs - photolytic and photocatalytic degradation of 
three pharmaceuticals (sulfamethazin, febantel and praziquantel) from different groups. In the 
experiments with UV-C radiation both photolytic and photocatalytic degradation processes occur, 
whereas with UV-A radiation only photocatalytic treatment was driven. Although photocatalytic 
experiments with UV-A are not as efficient as those with UV-C, they have a potential for practical 
use since natural UV-A solar radiation, which lowers the overall cost of the treatment, can be used. 
 
Keywords: photolysis, photocatalysis, TiO2 film, pharmaceuticals  
 
Introduction 
 
One of the major challenges faced around the world is the limited quantity of unpolluted 
water available for future use as a resource for drinking water supply. Until recently the 
impact of chemical pollution has focused on the conventional “priority” pollutants 
(pesticides, polycyclic aromatic hydrocarbons (PAHs), persistent organic pollutants 
(POPs), heavy metals...). However, the growing use of pharmaceuticals worldwide, the so-
called emerging contaminants, has become a new environmental problem, which has great 
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concern among scientists in the last decade (Glassmeyer et al., 2008). Pharmaceuticals are 
complex molecules with different physicochemical and biological properties and 
functionalities. They have an important role in the treatment and prevention of disease in 
both humans and animals. Because of their nature they can also have unintended effects on 
animals and micro-organisms in the environment. As these compounds are frequently 
transformed in the body, a combination of unchanged pharmaceuticals and metabolites are 
excreted by humans. Human-use pharmaceuticals enter raw sewage via urine and feces and 
by improper disposal. These pharmaceuticals are discharged from private households and 
from hospitals and eventually reach municipal wastewater treatment plants (WWTPs). If 
pharmaceuticals are only partially eliminated, residual quantities enter surface or 
groundwater. However, direct inputs into natural waters are also possible through 
veterinary practice when manure is spread on fields. If not degraded, pharmaceuticals may 
end up in soil or groundwater. 
Although pharmaceuticals concentration is too low to pose an acute risk, it is not known 
whether other receptors in non-target organisms are sensitive to individual residues, or the 
pharmaceuticals that share a common mechanism of action exhibit synergetic effects. 
However, due to the widespread usage of pharmaceuticals in everyday life and because 
their purpose is to produce specific biological effects on organisms or living tissue, 
unwanted environmental effects are to be expected. Since pharmaceuticals are continually 
being introduced into the environment, they do not need to be persistent to cause negative 
effects. 
So far, strategies for wastewater treatment have not been focused on the elimination of 
organic micropollutants. The precautionary principle with regard to drinking water supply 
and wastewater treatment implies an efficient removal of all potential harmful constituents. 
However, pharmaceuticals recently detected in surface water and drinking water are not 
included in the regulatory list of environmental pollutants. As a consequence the indirect 
potable water reuse of municipal WWTP discharges leads to an exposure of the 
environment and ultimately of drinking water to these chemicals. Therefore, the removal 
efficiency of existing wastewater treatment must be optimized and new technologies need 
to be developed (Petrović et al., 2013). 
AOPs are generally defined as aqueous phase oxidation methods based on the generation 
of highly reactive oxidative species such as hydroxyl radicals (OH
•
) and the reducing 
hydrated electrons (e
-
aq), that are capable to degrade/destruct the target pollutant(s). Key 
AOPs include heterogeneous and homogeneous photocatalysis based on ultraviolet (UV), 
solar or visible irradiation; electrolysis; ozonation; the Fenton's reagent; high-power 
ultrasound and wet air oxidation, (Oppenländer, 2003; Comninellis et al., 2008; Klavariotti 
et al., 2009). 
The main objective of this research work was to study the applicability of different AOPs 
for the degradation of three pharmaceuticals in model water: photochemical (UV-C, UV-
A) and photocatalytic (UV-C or UV-A with TiO2) degradation process. 
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The semiconductor photocatalyst TiO2 can photocatalytically degrade and mineralize a large 
variety of environmental contaminations, including organic and inorganic materials, to CO2, 
H2O, and harmless inorganic anions (Mills and Le Hunte, 1997; Hoffmann et al., 1995). As 
TiO2 is illuminated by UV radiation with wavelengths below 400 nm, the photons excite 
valence band electrons across the band gap into conduction band, leaving holes in the valence 
band (Linsebigler, 1995). The holes in TiO2 will react with water molecules or OH
-
 ions and 
then produce hydroxyl radicals or directly oxidize adsorbed organics, so the natural solar 
radiation could be activator (it consists of 3-5% of UV radiation) of the process (Ljubas, 2005). 
TiO2 can be applied in the form of a suspension (slurry) or it can be immobilised by different 
techniques on different substrates, i.e. reactor walls (Šegota et al., 2011; Ćurković et al., 2014). 
The use of a slurry TiO2 system requires an additional process step to be entailed for 
postseparation of the catalyst. This separation process is crucial to avoid the loss of catalyst 
particles and to avoid the introduction of TiO2 in the treated water as the new pollutant (Chong 
et al., 2010). The catalyst recovery can be achieved nowadays through membrane filtration 
(Chong, 2010) or through a magnetic separation, if the TiO2 particles were coupled to a 
magnetic material (Zhao et al., 2002). Nevertheless, several important operating issues with 
slurry TiO2 still remain even with a membrane integration process (types of membrane, pore 
size, regeneration or backwashing, and fouling (Chong et al., 2010)) or with the magnetic 
separation process (Beydoun et al., 2000; Ljubas et al., 2014). Coupling with magnetic material 
causes loosing of the activity of the TiO2 due to the recombination process between magnetic 
material and TiO2, or, if insulation layer is used, the particles dimensions increase and the 
overall photocatalytic surface area decreases. The main problems with regard to this process 
relate to the efficiency due to the limited mass transfer and/or technical effort leading to high 
operational cost. 
The photocatalytic oxidation processes in this research will be performed with the 
immobilized photocatalysts in a form of thin ceramic film using a new approach that has 
been developed with the aim to avoid the above mentioned problems within catalyst 
separation step (Šegota et al., 2011).  
The effectiveness of each AOP and their combinations are examined on the basis of 
conversion of targeted pharmaceutical(s), which was monitored by HPLC coupled to mass 
spectrometry. 
 
Materials and methods  
 
Chemicals 
 
Analytical standards (Fig. 1) of febantel (FBT), praziquantel (PZQ) and sulfamethazine 
(SMT) were obtained from Veterina Animal Health (Kalinovica, Croatia). For 
chromatographic analysis methanol (J. T. Baker, Deventer, Netherlands), acetonitril (J. T. 
Baker, Deventer, Netherlands) and formic acid (Merck, Darmstadt, Germany) were used. 
All solvents used were HPLC-grade. Ultra pure water was prepared by a Millipore 
2
nd
 International and 6
th
 Croatian Scientific and Professional Conference Water for all 
 
18
th
 March 2016 
Osijek, Croatia 
Proceedings 
 
 
31 
 
Simplicity UV system (Millipore Corporation, Billerica, MA, USA) and was used for all 
experiments. Investigated pharmaceuticals were prepared in aqueous solutions in the 
concentrations of 1 mg/L and 10 mg/L. For FBT and PZQ in the standard solutions 0,01% 
of organic solvent was added for enhancement of solubility. 
 
   
 
Febantel  Praziquantel  Sulfamethazine 
 
Fig. 1. Chemical structures of the investigated pharmaceuticals 
 
Photocatalytic experiments 
 
All experiments were carried out in 0.11 L borosilicate glass cylinders as the reactors (Fig. 2): 
A - Reactor - a borosilicate glass with a sol-gel TiO2 film (with the addition of PEG), and 
B - Reactor - a borosilicate glass cylinder without coating. 
Details about the preparation of the TiO2 film, with the addition of PEG, can be found 
elsewhere (Šegota et al., 2011; Ćurković et al., 2014). 
Two UV-radiation lamps were used: model Pen-Ray CPQ 7427, with λmax = 365 nm (UV-
A) and model Pen Ray 90-0004-07 with λmax = 254 nm (UV-C), both lamps are 
manufactured by UVP (Upland, CA, USA).  
 
 
 
Fig. 2. A scheme of the photoreactor system: 1 – reactor with a solution of the pharmaceuticals,  
2 – PTFE magnetic stir bar, 3 – magnetic stirrer, 4 – UV-A or UV-C lamp, 5 – thermostatic bath,  
6 – TiO2 film (in photocatalytic experiments) 
O
NH S
O
CH3
NH
NNH
O
O
CH3
OO
CH3
N
N
O
O
NH2 S NH
N
N
CH3
CH3
O
O
O2
Cooling 
water - in
Cooling 
water - out
U
V
  
ra
d
ia
ti
o
n
1
2
3
4
5
6
2
nd
 International and 6
th
 Croatian Scientific and Professional Conference Water for all 
 
18
th
 March 2016 
Osijek, Croatia 
Proceedings 
 
 
32 
 
The removal/degradation of the pharmaceuticals was ensured with continuous purging 
with air (O2) to the solution, using three different conditions, as in (Ljubas, 2015): 
(a) under UV illumination in the absence of TiO2 film (photolysis),  
(b) “in the dark” (without UV radiation) with TiO2 film (adsorption),  
(c) under UV illumination in the presence of TiO2 film (photocatalysis).  
The sample aliquots (2 mL) were taken from the reactor, shown in Fig. 2, at certain 
reaction intervals: usually in 0, 15, 30, 45, 60, 90 and 120 minutes, but in some 
experiments more often in first 15 minutes. 
 
Analytical procedures 
 
In order to monitor the degradation of all three pharmaceuticals and the formation of their 
degradation products, sample aliqouts were analyzed using LC-MS/MS. Liquid 
chromatography analysis was performed using Agilent (Santa Clara, CA, USA) series 
1200 coupled to an Agilent 6410 triple-quadrupole mass spectrometer equipped with an 
ESI interface.  
Chromatographic separation was achieved using a Synergy Fusion C18 embedded column 
for SMT and PZQ (150 mm×2.0 mm, particle size 4 μm) supplied by Phenomenex Co. and 
the column used for chromatographic separation of the degradation products for FBT was 
Synergy Polar C18 (100 mm x 2.0 mm, particle size 2.5 µm) supplied by Phenomenex Co, 
too. The mobile phase consisted of 0.1% formic acid in MilliQ water as eluent A and 0.1% 
formic acid in acetonitrile as eluent B in gradient elution mode.  
For FBT analysis the gradient elution was started with 8% of B which was held for 3 min. 
During the next 12 min the percentage of B was increased linearly to 95% and was held for 
5 min. During 0.01 min it was set to 0% of B and was held for 10 min for equilibration of 
column. 
The flow rate for SMT and PZQ analysis was 0.2 mL/min and the injection volume was 5 
μL for all analyses. The gradient elution started with 0% of B, during 2.30 min it rose to 
8% of B followed with a rise to 10% of B in the 6
th
 min, to 30% in the 11
th
 min, to 60% in 
the 15
th
 min and to 95% in the 18
th
 min. During a 10-min period that followed, the content 
of B was constant at 95%. In the 29
th
 minute (28.10 min), the content of B dropped to 0% 
and remained that way until the 40
th
 min, which was the end of the run. 
Parameters for the mass spectrometer for all the pharmaceuticals were the following: 
drying gas temperature - 350 °C; capillary voltage - 4.0 kV; drying gas flow - 11 Lmin-1, 
and nebulizer pressure - 35 psi. Positive-mode electrospray ionization (ESI) was used for 
ionization. Fragmentor voltages were optimized to obtain precursor ions of best abundance 
for the SMT and degradation products. After the selection of precursor ions, product ions 
were obtained based on optimized collision energies. Instrument control, data acquisition 
and evaluation were done using the Agilent MassHunter 2003–2007 Data Acquisition for 
Triple Quad B.01.04 (B84) software. 
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Results and discussion 
 
As can be seen on the Fig. 3, for all investigated pharmaceuticals using only UV-A 
radiation as a degradation mean did not result in degradation.  
 
 
 
a) 
 
b) 
 
c) 
 
Fig. 3. Degradation of pharmaceuticals: a) febantel, b) praziquantel, c) sulfamethanzine 
 
 
However, adding TiO2 film as the catalyst enhanced degradation, so FBT and PZQ were 
degraded within investigated time (240 min). SMT did not degrade completely during the 
investigated time of 180 min but 90% of the compound was degraded with the trend of 
complete degradation. More successful degradation was achieved when the UV-C light 
was used with and without the catalyst (Čizmić et al., 2016; Babić et al., 2015). 
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All investigated degradations followed the first order kinetics model which is confirmed 
with R2 higher than 0.97 (Table 1). Higher efficiency of UV-C radiation for degradation 
can be seen when comparing the degradation rates of investigated degradations.  
 
Table 1. Parameters of the first order kinetic models 
 
 
 
 
From the kinetic model parameters it is obvious that the degradation of all pharmaceuticals 
is significantly faster when UV-C radiation was applied - almost ten times faster 
degradation than in the case when UV-A radiation was applied. But, it should be 
mentioned that the UV-A radiation source for the process of SMT degradation (and of 
other organic pollutants) could be the UV-A part of solar radiation that reaches the Earth’s 
surface and if solar radiation is used, then the costs of ensuring UV-A radiation could be 
significantly lowered (it should be considered in future experiments and in the real-scale 
reactor design) (Babić et al., 2015). 
Five photodegradation products of PZQ were identified using MS/MS analysis. 
Photoproducts reached their maximum concentration after 60 min and none of them was 
completely degraded in the investigated period of 120 min. Similar formation/degradation 
profiles were obtained in both processes, i.e. photolysis and photocatalysis (Fig. 4). 
k (min-1) R2 t½ (min)
P
R
A
ZI
Q
U
A
N
TE
L
UV-C 0.22 1.0000 3.13
UV-C + TiO2 0.24 1.0000 2.90
UV-A +TiO2 0.02 0.9949 34.48
SU
LF
A
M
ET
H
A
ZI
N
E
UV-C 0.11 0.9762 6.24
UV-C + TiO2 0.10 0.9927 6.86
UV-A +TiO2 0.01 0.9991 63.01
FE
B
A
N
TE
L UV-C 0.26 0.9970 2.67
UV-C + TiO2 0.32 0.9836 2.15
UV-A +TiO2 0.02 0.9900 30.27
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Fig. 4. Formation and degradation of praziquantel degradation products 
 
 
The formation and degradation profiles of FBT photodegradation products are shown on 
Fig. 5. In total, five photodegradation products were identified; two of them are present in 
the reaction solution even after 60 min of degradation and complete degradation of parent 
compound. 
 
 
 
Fig. 5. Evolution and degradation of febantel degradation products 
 
 
As can be seen on Fig. 6, evolution and degradation of SMT photodegradation products 
under UV-C radiation are enhanced by presence of TiO2. In total, five photodegradation 
products were identified. They reached their maximum concentration after 30 min and 20 
min during photolytic and photocatalytic degradation, respectively. 
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Fig. 6. Evolution and degradation of sulfamethazine degradation products 
 
 
Conclusions 
 
Based on the experimental results, the following conclusions can be drawn: 
­ with UV-C radiation both photolytic and photocatalytic degradation processes occur for 
all three investigated compounds 
­ for sulfamethazine degradation - presence of the TiO2 film in the UV-C/TiO2 
photocatalysis system had a positive influence in terms of faster degradation of 
photoproducts while in the case of  degradation of praziquantel and febantel it was not 
observed 
­ degradation of all three pharmaceuticals is in average ten times faster when UV-C 
radiation was applied instead of UV-A radiation 
­ with UV-A radiation only photocatalytic treatment was driven, photolytic degradation 
did not occur 
­ although UV-A photocatalytic experiments need more time than UV-C experiments, 
they have a potential for practical use since natural UV-A solar radiation could be used 
here, which lowers the overall cost of the treatment 
­ for each of the three investigated pharmaceuticals, using HPLC-MS/MS, five 
degradation products were identified during the degradation process.  
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